Streetbeat News

Analyst Ratings

PLUG

HC Wainwright reiterates a Buy rating for Plug Power, maintaining a $78 price target.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 2:31 pm

INTC

Benzinga's options scanner detected over 12 options trades for Intel (NASDAQ:INTC) totaling $662,160. Whales have been targeting a price range of $27.0 to $35.0 for Intel over the last 3 months. Goldman Sachs maintains a Sell rating on Intel with a price target of $27.

Portfolio Pulse from Benzinga Insights

May 30, 2023 | 2:16 pm

GPS

Deutsche Bank analyst Gabriella Carbone maintains a Buy rating on Gap (NYSE:GPS) and raises the price target from $10 to $11.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 2:13 pm

MSFT

Deutsche Bank analyst Brad Zelnick maintains a Buy rating on Microsoft (NASDAQ:MSFT) and raises the price target from $340 to $380.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 2:13 pm

BIG

Deutsche Bank analyst Krisztina Katai maintains a Hold rating on Big Lots (NYSE:BIG) and lowers the price target from $8 to $6.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 2:13 pm

AVGO

BMO Capital analyst Ambrish Srivastava maintains an Outperform rating on Broadcom (NASDAQ:AVGO) and raises the price target from $750 to $890.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 2:12 pm

VALN

HC Wainwright & Co. analyst Edward White reiterates a Buy rating on Valneva (NASDAQ:VALN) and maintains a $22 price target.

Portfolio Pulse from richadhand@benzinga.com

May 30, 2023 | 2:11 pm

ICFI

Barrington Research analyst Kevin Steinke reiterated an Outperform rating on ICF International (NASDAQ:ICFI) and maintained a $138 price target.

Portfolio Pulse from richadhand@benzinga.com

May 30, 2023 | 2:10 pm

TFX

In the last quarter, Teleflex (NYSE:TFX) received 3 somewhat bullish and 3 indifferent analyst ratings, with an average price target of $284.5, implying an upside from the current price of $232.635. The average price target has increased by 17.08% over the past month.

Portfolio Pulse from Benzinga Insights

May 30, 2023 | 2:07 pm

MRNS

In the last quarter, Marinus Pharma (NASDAQ:MRNS) received 3 bullish and 6 somewhat bullish analyst ratings. The average 12-month price target for the stock is $24.22, representing a 6.85% decrease from the previous average of $26.00.

Portfolio Pulse from Benzinga Insights

May 30, 2023 | 2:06 pm